222 related articles for article (PubMed ID: 25537031)
1. [The revolution of the CRISPR is underway].
Gilgenkrantz H
Med Sci (Paris); 2014 Dec; 30(12):1066-9. PubMed ID: 25537031
[No Abstract] [Full Text] [Related]
2. Editing and investigating genomes with TALE and CRISPR/Cas systems: applications of artificial TALE and CRISPR-Cas systems.
Giovannangeli C; Concordet JP
Methods; 2014 Sep; 69(2):119-20. PubMed ID: 25248487
[No Abstract] [Full Text] [Related]
3. CRISPR adaptation in Escherichia coli subtypeI-E system.
Kiro R; Goren MG; Yosef I; Qimron U
Biochem Soc Trans; 2013 Dec; 41(6):1412-5. PubMed ID: 24256229
[TBL] [Abstract][Full Text] [Related]
4. Adaptation in CRISPR-Cas Systems.
Sternberg SH; Richter H; Charpentier E; Qimron U
Mol Cell; 2016 Mar; 61(6):797-808. PubMed ID: 26949040
[TBL] [Abstract][Full Text] [Related]
5. [A new method in biotechnology].
Hofmann-Aßmus M
MMW Fortschr Med; 2015 Apr; 157(7):75. PubMed ID: 26012467
[No Abstract] [Full Text] [Related]
6. [The affair "Crispr-Cas9" or genetically enhanced humanity].
Nau JY
Rev Med Suisse; 2014 Jun; 10(436):1428-9. PubMed ID: 25055481
[No Abstract] [Full Text] [Related]
7. Targeted mutagenesis in Zea mays using TALENs and the CRISPR/Cas system.
Liang Z; Zhang K; Chen K; Gao C
J Genet Genomics; 2014 Feb; 41(2):63-8. PubMed ID: 24576457
[TBL] [Abstract][Full Text] [Related]
8. Five big mysteries about CRISPR's origins.
Ledford H
Nature; 2017 Jan; 541(7637):280-282. PubMed ID: 28102279
[No Abstract] [Full Text] [Related]
9. Computational Detection of CRISPR/crRNA Targets.
Biswas A; Fineran PC; Brown CM
Methods Mol Biol; 2015; 1311():77-89. PubMed ID: 25981467
[TBL] [Abstract][Full Text] [Related]
10. Evolutionary causes and consequences of diversified CRISPR immune profiles in natural populations.
England WE; Whitaker RJ
Biochem Soc Trans; 2013 Dec; 41(6):1431-6. PubMed ID: 24256233
[TBL] [Abstract][Full Text] [Related]
11. Gene targeting technologies in rats: zinc finger nucleases, transcription activator-like effector nucleases, and clustered regularly interspaced short palindromic repeats.
Mashimo T
Dev Growth Differ; 2014 Jan; 56(1):46-52. PubMed ID: 24372523
[TBL] [Abstract][Full Text] [Related]
12. [From the bacterial CRISPR locus, an adaptative immune system equivalent, to a universal editing tool].
Friot A; Dekeyzer B; Guingand A; Guguin J; Joly A; Vuillier S
Med Sci (Paris); 2018 May; 34(5):395-396. PubMed ID: 29900837
[No Abstract] [Full Text] [Related]
13. Plant genome engineering in full bloom.
Lozano-Juste J; Cutler SR
Trends Plant Sci; 2014 May; 19(5):284-7. PubMed ID: 24674878
[TBL] [Abstract][Full Text] [Related]
14. CRISPR Primer Designer: Design primers for knockout and chromosome imaging CRISPR-Cas system.
Yan M; Zhou SR; Xue HW
J Integr Plant Biol; 2015 Jul; 57(7):613-7. PubMed ID: 25319067
[TBL] [Abstract][Full Text] [Related]
15. Cost and benefits of clustered regularly interspaced short palindromic repeats spacer acquisition.
Bradde S; Mora T; Walczak AM
Philos Trans R Soc Lond B Biol Sci; 2019 May; 374(1772):20180095. PubMed ID: 30905281
[TBL] [Abstract][Full Text] [Related]
16. Deciphering and shaping bacterial diversity through CRISPR.
Briner AE; Barrangou R
Curr Opin Microbiol; 2016 Jun; 31():101-108. PubMed ID: 27045713
[TBL] [Abstract][Full Text] [Related]
17. Just how Lamarckian is CRISPR-Cas immunity: the continuum of evolvability mechanisms.
Koonin EV; Wolf YI
Biol Direct; 2016 Feb; 11(1):9. PubMed ID: 26912144
[TBL] [Abstract][Full Text] [Related]
18. Targeted genome editing in primate embryos.
Guo X; Li XJ
Cell Res; 2015 Jul; 25(7):767-8. PubMed ID: 26032266
[TBL] [Abstract][Full Text] [Related]
19. Inactivation of an integrated antibiotic resistance gene in mammalian cells to re-enable antibiotic selection.
Ni P; Zhang Q; Chen H; Chen L
Biotechniques; 2014; 56(4):198-201. PubMed ID: 24724846
[TBL] [Abstract][Full Text] [Related]
20. CRISPR on the Move in 2019.
Barrangou R
CRISPR J; 2019 Feb; 2():1-2. PubMed ID: 31021232
[No Abstract] [Full Text] [Related]
[Next] [New Search]
